BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34075124)

  • 1. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.
    Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y
    Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells.
    Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Mizuguchi H; Sato Y
    Sci Rep; 2019 Mar; 9(1):3630. PubMed ID: 30842516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.
    Yamoah MA; Moshref M; Sharma J; Chen WC; Ledford HA; Lee JH; Chavez KS; Wang W; López JE; Lieu DK; Sirish P; Zhang XD
    Int J Nanomedicine; 2018; 13():6073-6078. PubMed ID: 30323594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
    Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
    Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system.
    Tano K; Yasuda S; Kuroda T; Saito H; Umezawa A; Sato Y
    PLoS One; 2014; 9(10):e110496. PubMed ID: 25347300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells.
    Tsujimoto H; Katagiri N; Ijiri Y; Sasaki B; Kobayashi Y; Mima A; Ryosaka M; Furuyama K; Kawaguchi Y; Osafune K
    PLoS One; 2022; 17(11):e0275600. PubMed ID: 36378656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.
    Ito E; Miyagawa S; Takeda M; Kawamura A; Harada A; Iseoka H; Yajima S; Sougawa N; Mochizuki-Oda N; Yasuda S; Sato Y; Sawa Y
    Sci Rep; 2019 Feb; 9(1):1881. PubMed ID: 30760836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Oligodendrogenic Spinal Neural Progenitor Cells From Human Induced Pluripotent Stem Cells.
    Khazaei M; Ahuja CS; Fehlings MG
    Curr Protoc Stem Cell Biol; 2017 Aug; 42():2D.20.1-2D.20.14. PubMed ID: 28806852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine.
    Nagashima T; Shimizu K; Matsumoto R; Honda H
    Sci Rep; 2018 Aug; 8(1):12427. PubMed ID: 30127448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes.
    Lei W; Feng T; Fang X; Yu Y; Yang J; Zhao ZA; Liu J; Shen Z; Deng W; Hu S
    Stem Cell Res Ther; 2018 Mar; 9(1):56. PubMed ID: 29523209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.
    Uosaki H; Fukushima H; Takeuchi A; Matsuoka S; Nakatsuji N; Yamanaka S; Yamashita JK
    PLoS One; 2011; 6(8):e23657. PubMed ID: 21876760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells.
    Matsumoto R; Shimizu K; Nagashima T; Tanaka H; Mizuno M; Kikkawa F; Hori M; Honda H
    Regen Ther; 2016 Dec; 5():55-63. PubMed ID: 31245502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of residual undifferentiated induced pluripotent stem cells (iPSCs) using irradiation for safe clinical applications of iPSC-derived cardiomyocytes.
    Takeda M; Ito E; Minami K; Harada A; Mochizuki-Oda N; Sawa Y; Miyagawa S
    Biochem Biophys Res Commun; 2021 Oct; 574():91-96. PubMed ID: 34450429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids.
    Marzano M; Bejoy J; Cheerathodi MR; Sun L; York SB; Zhao J; Kanekiyo T; Bu G; Meckes DG; Li Y
    Cells; 2019 Aug; 8(9):. PubMed ID: 31466320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral vector based gene transfection with human induced pluripotent stem cells derived cardiomyocytes.
    Tan S; Tao Z; Loo S; Su L; Chen X; Ye L
    Sci Rep; 2019 Oct; 9(1):14404. PubMed ID: 31591436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guide to generating and using hiPSC derived NPCs for the study of neurological diseases.
    Topol A; Tran NN; Brennand KJ
    J Vis Exp; 2015 Feb; (96):e52495. PubMed ID: 25742222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient methods to obtain homogeneous dorsal neural progenitor cells from human and mouse embryonic stem cells and induced pluripotent stem cells.
    Zhang M; Ngo J; Pirozzi F; Sun YP; Wynshaw-Boris A
    Stem Cell Res Ther; 2018 Mar; 9(1):67. PubMed ID: 29544541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.